{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Keck School of Medicine Continuing Medical Education
  • Sign In
  • Browse By Specialty
  • Live Courses
  • Online Courses
  • RSS Calendar
  • Learning from Teaching
  • Policies
  • About
  • Contact
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

For USC users with a @med.usc.edu email address: click the Sign in with your @med.usc.edu Email button. For all others, including creating a new account, click the Sign in with your Email and Password button.

To access the help page for assistance logging in (existing accounts) or resetting your password click here.

Sign in with your @med.usc.edu Email
Sign in with your Email and Password
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ADN
  • APCC
  • BSN
  • CNM
  • CPE
  • CRC
  • CRC/APCC
  • DDS
  • DNP
  • DO
  • DOS
  • DPM
  • DPT
  • DSW
  • DVM
  • EdD
  • EMT
  • FNP
  • LCSW
  • LVN
  • MA
  • MB
  • MD
  • MFT
  • MPH
  • MS
  • MSed
  • MSN
  • MSW
  • None
  • NP
  • OD
  • OOD
  • OT
  • Other
  • PA
  • PA-C
  • PharmD
  • PhD
  • PsyD
  • PT
  • RD
  • RDH
  • RN
  • RT
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
  • All Specialties
  • Anesthesiology
  • Chaplain/Spiritual Care
  • Dermatology
  • Emergency Medicine
  • Family Medicine
  • Internal Medicine
  • Neurology
  • Obstetrics and Gynecology
  • Ophthalmology
  • Pathology
  • Pediatrics
  • Physical Medicine and Rehabilitation
  • Psychiatry
  • Radiation Oncology
  • Radiology
  • Surgery
  • Urology
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

9th Annual USC Multi-Disciplinary Breast Cancer Symposium

  • Overview
  • Register
  • Faculty
  • Brochure
  • Schedule
Add to Calendar 9th Annual USC Multi-Disciplinary Breast Cancer Symposium 1/22/2022 7:00:00 AM 1/22/2022 5:05:00 PM America/Los_Angeles For More Details: https://keckusc.cloud-cme.com/breastcancer2022 Description: This program will review the current state-of-the-art for breast cancer management, highlighting the key components of multi-disciplinary treatment to include breast pathology, surgical oncology, reconstructive surgery, medical oncology, and radiation oncology. The format of this program will consist of lectures by international experts in their fields.The I-SPY2 clinical trial using an adaptive design to rapidly b... SLS Beverly Hills false MM/DD/YYYY


Date & Location
Saturday, January 22, 2022, 7:00 AM - 5:05 PM, SLS Beverly Hills

Credits
AMA PRA Category 1 Credits™ (7.75 hours), Non-Physician Attendance (7.75 hours)

Overview

This program will review the current state-of-the-art for breast cancer management, highlighting the key components of multi-disciplinary treatment to include breast pathology, surgical oncology, reconstructive surgery, medical oncology, and radiation oncology. The format of this program will consist of lectures by international experts in their fields.


The I-SPY2 clinical trial using an adaptive design to rapidly bring forth new agents in the neoadjuvant setting has been a significant advance in trial design, presented by the principal investigator of this trial. The prognostic significance of residual burden of cancer remaining in the breast after neoadjuvant chemotherapy has assumed increasing importance in recent times and will be a featured component of this seminar. Surgical treatment of the breast in patients who present with Stage IV disease has been controversial and will be discussed in detail. Recent advances in reconstructive microsurgery will be presented by one of the internationally prominent surgeons in the field. An update in the advances in partial breast and accelerated radiation techniques will be presented.


The understanding of the HER2 receptor continues to evolve, and the biology of the HER2 axis will be presented by one of the pioneers in our understanding of this phenomenon. Key talks in medical oncology will focus on HER2+ breast cancer therapeutics in the metastatic setting, the use of newer agents in metastatic ER+ cancers, and the evolution of immunotherapy as a central theme in the treatment of triple-negative breast cancer.


Objectives
By the end of the course, participants will be able to:

  1. Understand the prognostic value of residual cancer remaining after neoadjuvant chemotherapy.
  2. Identify the unique features of the I-SPY2 adaptive trial design.
  3. Evaluate patients as candidates for oncoplastic surgical procedures and procedures to prevent and treat lymphedema after axillary operations.
  4. Outline the biology of the HER2 axis and its role in treating metastatic cancer.
  5. Describe the role of newer agents in treating metastatic ER+ cancers.
  6. Review newer concepts in treatment of triple negative breast cancers, including immunotherapy.
  7. Describe the evolving role of adjuvant partial breast radiation therapy, such as changes in dose/fractionation and technique.
  8. Understand the role of surgery for patients who initially present with Stage IV disease.

Accreditation
The Keck School of Medicine of the University of Southern California is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 7.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 


Additional Information

Cancellation Policy

Cancellations must be received by the USC Office of CME (by fax or email only) by January 18, 12:00 pm PST, for a refund. A $50 cancellation fee will be applied. In the event of course cancellation by conference organizers, all registration fees will be fully refunded.


Accessibility Statement
 
Keck School of Medicine Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodations, including dietary concerns, please contact the USC Office of CME at [email protected].


You are not logged in.

Please click the button below to login or create a new account before continuing.

Login or Create Account



The Keck School of Medicine Healthcare System School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.



Mitigation of Relevant Financial Relationships


Keck School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Jad Abdelsattar, MD
Keck Medicine of USC
Los Angeles , CA
Faculty
Nothing to disclose
Faculty Photos
Eric L Chang, MD, FASTRO
Professor and Chair
Keck School of Medicine of USC
Los Angeles, CA
Faculty
Nothing to disclose
Laura J Esserman, MD
Director, UCSF Breast Care Center
UCSF
San Francisco, CA
Faculty
Nothing to disclose
Karen Haiber, MD
USC
Pasadena, CA
Faculty
Nothing to disclose
Vera Hendrix, MD
Breast Surgical Oncology Fellow
USC
Los Angeles, CA
Faculty
Nothing to disclose
Kelly Hunt, MD
MD Anderson Cancer Center
Houston, TX
Faculty
Medical Advisory Board-Armada Health|Contracted Research-Research funding to my institution-Cairn Surgical|Contracted Research-Lumicell|Contracted Research-Eli Lilly and Company
Elizabeth Kraft, MD, physician
UNIVERSITY OF SOUTHERN CALIFORNIA
LOS ANGELES, CA
Faculty
Nothing to disclose
Janice Lu, MD, PhD
Northwestern University Feinberg School of Medicine
Chicago, IL
Faculty
Nothing to disclose
Maria E Nelson, MD
KSOM-Keck School of Medicine
Los Angeles, CA
Faculty
Nothing to disclose
Joyce O'Shaughnessy, MD
Medical Oncologist
Baylor University Medical Center/ Texas Oncology
Dallas, TX
Faculty
Consulting Fee-AstraZeneca|Consulting Fee-Bayer Corporation|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Daiichi Sankyo|Consulting Fee-Eisai, Inc.|Consulting Fee-Eli Lilly and Company|Consulting Fee-F. Hoffmann La Roche Ltd.|Consulting Fee-GE Healthcare Bio-Sciences|Consulting Fee-Genentech, Inc.|Consulting Fee-Gilead|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Novartis AG|Consulting Fee-Pfizer, Inc.|Consulting Fee-Pharmacyclics, Inc.|Consulting Fee-Sanofi-Aventis|Consulting Fee-Takeda Pharmaceuticals, Inc.|Consulting Fee-Seagen
Ketan Patel, MD
Associate Professor of Clinical Surgery
Keck School of Medicine
Los Angeles, CA
Faculty
Nothing to disclose
Mark Pegram, MD
Dr
Stanford University
Woodside , CA
Faculty
Consulting Fee-Pfizer, Inc.|Consulting Fee-Genentech, Inc.|Consulting Fee-Seagen|Consulting Fee-AstraZeneca/Daiichi
Hope S. Rugo, MD, FASCO
Professor of Medicine, Director, Breast Oncology and Clinical Trials Education
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Faculty
Grant or research support-Astra Zeneca|Grant or research support-Boehringer Ingelheim|Grant or research support-Daiichi Sankyo, Inc.|Grant or research support-Merck, Inc.|Grant or research support-Pfizer|Grant or research support-Novartis Pharmaceuticals|Grant or research support-Seattle Genetics|Grant or research support-Macrogenics|Grant or research support-Sermonix |Grant or research support-Polyphor|Grant or research support-Gilead Sciences, Inc.|Grant or research support-Ayala|Honoraria-Mylan|Honoraria-Puma|Honoraria-NAPO|Honoraria-Samsung
Faculty Photos
Stephen F. Sener, MD
Chief of Surgery
LAGMC
Los Angeles, CA
Faculty
Nothing to disclose
Simona F Shaitelman, MD
Associate Professor
UT MD Anderson Cancer Center
Houston, TX
Faculty
Grant or research support-Emerson Collective Foundation|Grant or research support-TAE Life Sciences|Grant or research support-Alpha Tau|Grant or research support-Artios Pharmaceuticals|Grant or research support-ExactSciences
Sara Tolaney, MD
Associate Professor of Medicine
Dana-Farber Cancer Institute
Boston, MA
Faculty
Contracted Research-AstraZeneca|Consulting Fee-AstraZeneca|Consulting Fee-Bristol-Myers Squibb|Contracted Research-Bristol-Myers Squibb|Contracted Research-Cyclacel|Consulting Fee-CytomX|Consulting Fee-BeyondSpring Pharmaceuticals|Consulting Fee-Eisai, Inc.|Contracted Research-Eisai, Inc.|Consulting Fee-Eli Lilly and Company|Contracted Research-Eli Lilly and Company|Consulting Fee-Ellipses Pharmaceuticals|Consulting Fee-F. Hoffmann La Roche Ltd.|Contracted Research-F. Hoffmann La Roche Ltd.|Consulting Fee-Gilead|Consulting Fee-Sanofi-Aventis|Contracted Research-Sanofi-Aventis|Consulting Fee-Gilead|Contracted Research-Gilead|Consulting Fee-Merck and Company, Inc.|Contracted Research-Merck and Company, Inc.|Consulting Fee-Novartis AG|Contracted Research-Novartis AG|Consulting Fee-Pfizer, Inc.|Contracted Research-Pfizer, Inc.|Consulting Fee-4D Pharma|Consulting Fee-Zymeworks|Consulting Fee-Mersana Therapeutics|Consulting Fee-Zentalis|Contracted Research-Nektar Therapeutics|Contracted Research-Nanostring|Consulting Fee-OncoSec|Consulting Fee-OncXerna|Consulting Fee-Infinity Therapeutics|Consulting Fee-BeyondSpring Pharmaceuticals|Consulting Fee-SeaGen|Contracted Research-SeaGen
Faculty Photos
Jason C. Ye, MD
Keck School of Medicine of USC
Los Angeles, CA
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novocure (Relationship has ended)|Speakers Bureau-Astra Zeneca (Relationship has ended)|Other: Travel support-QFix (Relationship has ended)

Saturday, January 22, 2022

Welcome and Opening Remarks
7:55AM - 8:00AM
Eric L Chang, MD, FASTRO
Measurement of Residual Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
8:00AM - 8:35AM
Kelly Hunt, MD
Question and Answer
8:35AM - 8:45AM
Update on the Management Strategies of Breast Cancer-Related Lymphedema
8:45AM - 9:20AM
Question and Answer
9:20AM - 9:30AM
I-SPY 2.2: A Responsive Adaptive Trial to Prioritize Promising Investigational Agents When They Matter Most
9:30AM - 10:05AM
Laura J Esserman, MD
Question and Answer
10:05AM - 10:15AM
Break
10:15AM - 10:30AM
Triple-Negative Breast Cancer: Past, Present and Future
10:30AM - 11:05AM
Sara Tolaney, MD
Question and Answer
11:05AM - 11:15AM
Therapeutic Strategies Targeting HER2
11:15AM - 11:50AM
Mark Pegram, MD
Question and Answer
11:50AM - 12:00PM
Lunch
12:00PM - 12:50PM
Improving Outcome for Patients with HR+ Breast Cancer, from Metastatic to Early Stage Disease
12:50PM - 1:20PM
Hope S. Rugo, MD, FASCO
Question and Answer
1:20PM - 1:30PM
Optimizing Therapy for Early Stage HER2+ Breast Cancer
1:30PM - 2:05PM
Joyce O'Shaughnessy, MD
Question and Answer
2:05PM - 2:15PM
Partial Breast Irradiation Updates
2:15PM - 2:50PM
Simona F Shaitelman, MD
Question and Answer
2:50PM - 3:00PM
Break
3:00PM - 3:15PM
Surgery for de novo Stage IV Breast Cancer
3:15PM - 3:50PM
Stephen F. Sener, MD
Question and Answer
3:50PM - 4:00PM
Cases
4:00PM - 4:45PM
Jad Abdelsattar, MD
Vera Hendrix, MD
Elizabeth Kraft, MD, physician
Karen Haiber, MD
Question and Answer
4:45PM - 5:00PM
Closing Remarks
5:00PM - 5:05PM

USC Office of Continuing Medical Education

©2022 CloudCME®